Related Experiment Video
Updated: Aug 10, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
Amir Hossein Behnoush1,2, Parnian Shobeiri1,2,3,4, Pegah Bahiraie5
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Insights
This study found elevated chemerin levels in chronic kidney disease (CKD) patients, suggesting its potential as an inflammatory biomarker. Further research is needed to explore chemerin
Area of Science:
- Biochemistry
- Nephrology
- Immunology
Background:
- Chemerin is recognized for its role as an inflammatory biomarker.
- Chronic kidney disease (CKD) is a significant global health concern associated with high mortality and morbidity.
- Previous studies have explored chemerin levels in CKD patients, necessitating a comprehensive review.
Purpose of the Study:
- To systematically review and meta-analyze the association between chemerin levels and chronic kidney disease.
- To investigate chemerin as a potential biomarker in various stages of CKD, including end-stage renal disease.
Main Methods:
- A systematic search was conducted across PubMed, Scopus, Embase, and Web of Science databases.
- Studies comparing chemerin levels in CKD patients (including hemodialysis patients) with healthy controls were included.
- Random effects meta-analysis was employed to calculate the standardized mean difference (SMD) and 95% confidence intervals (CI).
Main Results:
- Eight studies involving 875 participants were analyzed, all demonstrating high quality.
- Meta-analysis revealed significantly higher chemerin levels in CKD patients compared to healthy controls (SMD 2.15, 95% CI 0.83-3.48, p<0.01).
- Hemodialysis patients also exhibited statistically higher chemerin levels than controls (SMD 2.10, 95% CI 0.58-3.62, p=0.01).
Conclusions:
- Chemerin shows potential as a valuable biomarker for CKD, indicating underlying inflammatory pathways.
- Further investigation is warranted to elucidate the clinical applications and pathophysiological role of chemerin in CKD.
Introduction:
Chemerin as an inflammatory biomarker has gained attention in its biomarker capability. Several studies measured its levels in chronic kidney disease (CKD), as one of the common non-communicable causes of mortality and morbidity. Hence, this systematic review and meta-analysis aimed to investigate this association.
Methods:
PubMed, Scopus, Embase, and the Web of Science databases were systematically searched for studies investigating chemerin levels in any CKD stage (including end-stage renal disease patients undergoing hemodialysis (HD)) and comparing it with healthy controls. Random effect meta-analysis was performed to calculate the standardized mean difference (SMD) and 95% confidence interval (CI).
Results:
A total of eight studies were included, comprised of 875 individuals, with a mean age of 56.92 ± 11.78 years. All studies had high quality based on the New Castle-Ottawa Scale (NOS). Meta-analysis revealed significantly higher levels of chemerin in CKD patients compared to healthy controls (SMD 2.15, 95% CI 0.83-3.48, p-value<0.01). Additionally, HD patients had statistically higher levels of chemerin than controls (SMD 2.10, 95% CI 0.58-3.62, p-value=0.01). In meta-regression, publication year accounted for 23.50% and 24.17% of heterogeneity for these analyses, respectively.
Conclusion:
Chemerin can be potentially used as a biomarker in CKD patients, which can suggest the inflammatory pathways for the disease. Further research is warranted for the assessment of its clinical applications and enlightening its role in the pathophysiology of CKD.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury II: Pathophysiology

